Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

YING Yin, XIA Zhongni, ZHU Jun, ZOU Jie. Treatment analysis and pharmaceutical care for one infant with purulent meningitis and renal insufficiency[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(3): 285-288. doi: 10.3969/j.issn.1006-0111.2018.03.021
Citation: YING Yin, XIA Zhongni, ZHU Jun, ZOU Jie. Treatment analysis and pharmaceutical care for one infant with purulent meningitis and renal insufficiency[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(3): 285-288. doi: 10.3969/j.issn.1006-0111.2018.03.021

Treatment analysis and pharmaceutical care for one infant with purulent meningitis and renal insufficiency

doi: 10.3969/j.issn.1006-0111.2018.03.021
  • Received Date: 2017-08-07
  • Rev Recd Date: 2017-09-15
  • Objective To discuss how the clinical pharmacists participated in the treatment of pediatric purulent meningitis and conducted drug monitoring. Methods Clinical pharmacists involved the whole process of treatment for a purulent meningitis infant with renal insufficiency, evaluated medication history, conducted therapeutic drug monitoring and designed an individualized medication treatment plan with clinical physicians. Results Clinical pharmacists assisted clinicians with their pharmacy expertise, and developed individualized drug dosing regimen to achieve effective therapy and medication safety. Conclusion Clinical pharmacists play an important role in providing individualized pharmaceutical care for patients, optimizing the treatment plan and improving the rational drug use.
  • [1] 汪复, 张婴元.实用抗感染治疗学[M].北京:人民卫生出版社,2004.
    [2] Tunkel AR, Hartman BJ, Kaplan SL, et al.Practice guidelines for the management of bacterial meningitis[J].Clin Infect Dis, 2004, 39(9):1267-1284.
    [3] Le Saux N.Guidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than one month of age[J].Paediatr Child Health, 2014, 19(3):141-152.
    [4] Vvan de Beek D, Cabellos C, Dzupova O, et al.ESCMID guideline:diagnosis and treatment of acute bacterial meningitis[J].Clin Microbiol Infect, 2016, 22(Suppl3):S37-S62.
    [5] 万古霉素临床应用剂量专家组.万古霉素临床应用剂量中国专家共识[J].中华传染病杂志, 2012, 30(11):641-646.
    [6] 万古霉素临床应用中国专家共识(2011版)[J].中国新药与临床杂志, 2011,30(8):561-573.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(3713) PDF downloads(391) Cited by()

Related
Proportional views

Treatment analysis and pharmaceutical care for one infant with purulent meningitis and renal insufficiency

doi: 10.3969/j.issn.1006-0111.2018.03.021

Abstract: Objective To discuss how the clinical pharmacists participated in the treatment of pediatric purulent meningitis and conducted drug monitoring. Methods Clinical pharmacists involved the whole process of treatment for a purulent meningitis infant with renal insufficiency, evaluated medication history, conducted therapeutic drug monitoring and designed an individualized medication treatment plan with clinical physicians. Results Clinical pharmacists assisted clinicians with their pharmacy expertise, and developed individualized drug dosing regimen to achieve effective therapy and medication safety. Conclusion Clinical pharmacists play an important role in providing individualized pharmaceutical care for patients, optimizing the treatment plan and improving the rational drug use.

YING Yin, XIA Zhongni, ZHU Jun, ZOU Jie. Treatment analysis and pharmaceutical care for one infant with purulent meningitis and renal insufficiency[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(3): 285-288. doi: 10.3969/j.issn.1006-0111.2018.03.021
Citation: YING Yin, XIA Zhongni, ZHU Jun, ZOU Jie. Treatment analysis and pharmaceutical care for one infant with purulent meningitis and renal insufficiency[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(3): 285-288. doi: 10.3969/j.issn.1006-0111.2018.03.021
Reference (6)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return